BSEBoard Meeting1d ago · 11 Aug 2026, 05:46 pm
Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday, 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015.
Syncom Formulations India Ltd-$ · 524470
✦ AI SummaryResults
Syncom Formulations India Ltd's board meeting outcome announced, with approval of unaudited financial results, limited review report, and other business matters. Resignations of directors and appointments of new directors and CFO. Final dividend recommendation and record date set.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Syncom Formulations India Ltd-$ - 524470 - Board Meeting Outcome for Outcome Of The 2/2026-27 Meeting Of The Board Of Directors Of The Company.
Attachments (1)
📄pdf
Download →
22fab449-8d97-4d29-8f46-ff33e5041a3e.pdf
View document text
SYNCOM/SE/2026-27 11th August, 2026
Online filing at: www.listing.bseindia.com and
https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp
To, To,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex, Bandra (E),
Mumbai (M.H.) 400 001 Mumbai- 400051
BSE CODE:524470 NSE SYMBOL: SYNCOMF
Sub: Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on
Tuesday, 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the
SEBI(LODR) Regulations, 2015.
Dear Sir/Madam,
This has in reference to our earlier communication vide letter No. SYNCOM/SE/2026-27 dated 6th
August, 2026 intimating the notice of the 2/2026-27 Meeting of the board of Directors of the
Company, pursuant to Regulation 29(1)(a) and Regulation 30 of SEBI (LODR) Regulations,2015 read
with Schedule III of the said Regulation.
We would like to inform that the Board of Directors of the Company, at its Meeting held on Tuesday,
11th August, 2026 at 4:00 P.M., has considered and approved the following business:-
1. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for
the Quarter ended 30th June, 2026.
2. Taken on record the Limited Review Report by the Auditors for the Standalone and Consolidated
Financial results of the company for the Quarter ended 30th June, 2026.
3. Approval for the Board’s Report and Notice of the 38th Annual General Meeting (AGM) to be
held on Wednesday the 30th day of September, 2026 at 2:00 P.M. through Video Conferencing /
Other Audio-Visual Means (VC/OAVM).
4. Finalization of the Annual Book Closure of the Company for the 38th AGM.
5. Finalization of the Cut-off Date for determining eligibility for participation in the Remote E-
voting and E-voting process at the 38th AGM.
6. Appointment of Scrutinizer for the conducting Remote E-voting as well as E-voting process at
38th AGM.
7. Appointment of Cost Auditor and the remuneration will be subject to ratification of the
shareholder at the ensuing AGM.
8. Appointment of Internal Auditor of the Company.
9. Noting the resignation of Shri Kedarmal Shankarlal Bankda (DIN: 00023050) from the position
of Whole-time Director with effect from the close of business hours on August 11, 2026.
10. Noting the resignation of Shri Vijay Shankarlal Bankda (DIN: 00023027) from the position of
Managing Director with effect from the close of business hours on August 11, 2026.
11. Noting resignation of Shri Rahul Vijay Bankda from the position of Chief Financial Officer
(CFO), with effect from the close of business hours on August 11, 2026.
12. Approved the appointment of Mrs. Rinki Ankit Bankda (DIN: 06946754) as an Additional
Director and further designated as Whole Time Director of the Company, with effect from August
12, 2026, subject to approval of members within in a period of 3 months from the date of
appointment.
13. Approval for the appointment of Shri Rahul Vijay Bankda (DIN: 00827827) as an Additional
Director and further designated as Managing Director of the Company, with effect from August
12, 2026, subject to approval of members within in a period of 3 months from the date of
appointment.
14. Approval for the appointment of Shri Ankur Vijay Bankda (DIN: 02328515) as Chief Financial
Officer (CFO) of the Company, with effect from August 12, 2026.
15. Approval for reappointment for Smt. Ruchi Jindal (DIN: 09633465) as Woman Independent
Director of the company with effect from 29th June, 2027 subject to approval of members in the
ensuing AGM.
16. Recommendation of the Final dividend of Re. 0.10/- (@ 10%) per equity share of Re. 1/- each,
subject to approval of the shareholders at the AGM.
The Record Date as Wednesday, September 23, 2026, in compliance with regulation 42(1) of the
Listing Regulations, to determine the list of shareholders entitled to receive the final dividend for the
Financial Year ended on March 31, 2026, payment of which shall be subject to the approval by the
members at the AGM. Details of the same is provided in Annexure 1
17. Consideration of other routine business matters.
The Board Meeting commenced at 4:00 P.M. and concluded at 04:45 P.M.
You are requested to please take on record our above said information for your reference and record
and disseminate on the portal of the BSE and NSE for information to the investors and members of
the Company.
Thanking you,
Yours faithfully,
For, SYNCOM FORMULATIONS (INDIA) LIMITED
CS VAISHALI AGRAWAL
COMPANY SECRETARY &
COMPLIANCE OFFICER
Annexure 1
Symbol / Type of Record Date Purpose
Security Code Security
SYNCOMF Equity Share 23.09.2026 For payment of final dividend @ 10% i.e. Rs.
0.10/- per Equity Share of the Company for the
year ended 31" March 2026, if approved by the
Shareholders of the Company in the ensuing
Annual General Meeting.